Literature DB >> 27723246

Comparison of five systems of classification of diabetic foot ulcers and predictive factors for amputation.

Byung-Joon Jeon1, Hwan Jun Choi2, Jin Seok Kang2, Min Sung Tak2, Eun Soo Park2.   

Abstract

Diabetes mellitus is a common metabolic disorder. Among various complications, diabetic neuropathy and peripheral vascular disorders are closely associated with diabetic foot ulcers (DFUs). Lower extremity ulcers and amputations are ongoing problems among individuals with diabetes. There are several classification systems for DFUs; however, no prognostic system has to date been accepted as the gold standard or the optimum prediction tool for amputations. A retrospective study was designed. Demographic data and baseline laboratory data were gathered and scored or evaluated using five representative DFU classification systems. These included (i) the diabetic ulcer severity score (DUSS); (ii) University of Texas (UT) diabetic wound classification; (iii) Meggitt-Wagner classification; (iv) depth of the ulcer, extent of bacterial colonisation, phase of ulcer and association aetiology (DEPA) scoring system; and (v) site, ischaemia, neuropathy, bacterial infection and depth (SINBAD) score. Finally, a statistical analysis was performed. A total of 137 patients were included in this study. During the follow-up, DFU had healed in 51·1% of subjects and 48·9% of the individuals underwent lower extremity amputations (LEAs). In a univariable logistic regression analysis, history of previous DFU, hypertension, neuropathy, haemoglobin, C-reactive protein (CRP) and ankle-brachial index (ABI) showed a statistically significant difference between the healed group and the LEA group. Moreover, the stages, grades or overall prognostic ability of all five classifications were highly associated with the overall occurrence of LEA. On multivariable logistic regression analysis of the risk of LEA, all classifications showed a significant positive trend with an increased number of amputations. All the five classification systems exhibited high sensitivity, specificity, classification accuracy, positive predictive, negative predictive and area under the curve (AUC) values. They showed substantial accuracy and their main variables were associated with LEA occurrence. The Wagner and UT systems, although they are relatively simple to assess, were better predictors of LEA.
© 2016 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Amputation; Classification; Diabetic foot ulcer

Mesh:

Year:  2016        PMID: 27723246      PMCID: PMC7949506          DOI: 10.1111/iwj.12642

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  36 in total

1.  Incidence of lower-extremity amputation in American Indians: the Strong Heart Study.

Authors:  Helaine E Resnick; Elizabeth A Carter; Jay M Sosenko; Susan J Henly; Richard R Fabsitz; Frederick K Ness; Thomas K Welty; Elisa T Lee; Barbara V Howard
Journal:  Diabetes Care       Date:  2004-08       Impact factor: 19.112

Review 2.  Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension.

Authors:  Michael F O'Rourke; Wilmer W Nichols
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

3.  Prevalence of peripheral vascular disease and its association with carotid intima-media thickness and arterial stiffness in type 2 diabetes: the Chennai urban rural epidemiology study (CURES 111).

Authors:  Rajendra Pradeepa; Sundarapandi Chella; Jayagopi Surendar; Karunakaran Indulekha; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Diab Vasc Dis Res       Date:  2014-03-13       Impact factor: 3.291

4.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

5.  Classification of diabetic foot wounds.

Authors:  L A Lavery; D G Armstrong; L B Harkless
Journal:  J Foot Ankle Surg       Date:  1996 Nov-Dec       Impact factor: 1.286

Review 6.  Preventing foot ulcers in patients with diabetes.

Authors:  Nalini Singh; David G Armstrong; Benjamin A Lipsky
Journal:  JAMA       Date:  2005-01-12       Impact factor: 56.272

7.  Recurrence of neuropathic ulceration following healing in a total contact cast.

Authors:  P A Helm; S C Walker; G F Pullium
Journal:  Arch Phys Med Rehabil       Date:  1991-11       Impact factor: 3.966

8.  Serial serum C-reactive protein to monitor recovery from acute hematogenous osteomyelitis in children.

Authors:  I Roine; I Faingezicht; A Arguedas; J F Herrera; F Rodríguez
Journal:  Pediatr Infect Dis J       Date:  1995-01       Impact factor: 2.129

9.  The DEPA scoring system and its correlation with the healing rate of diabetic foot ulcers.

Authors:  Nidal A Younes; Abla M Albsoul
Journal:  J Foot Ankle Surg       Date:  2004 Jul-Aug       Impact factor: 1.286

10.  Prognostic usefulness of metabolic syndrome compared with diabetes in Korean patients with critical lower limb ischemia treated with percutaneous transluminal angioplasty.

Authors:  Ki-Bum Won; Hyuk-Jae Chang; Sung-Jin Hong; Young-Guk Ko; Myeong-Ki Hong; Yangsoo Jang; Donghoon Choi
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

View more
  15 in total

1.  Factors associated with lower-extremity amputation in patients with diabetic foot ulcers in a Chinese tertiary care hospital.

Authors:  Zi Guo; Chun Yue; Qiang Qian; Honghui He; Zhaohui Mo
Journal:  Int Wound J       Date:  2019-08-25       Impact factor: 3.315

2.  [Interpretation of 2019 International Working Group on Diabetic Foot guidelines on the prevention and management of diabetic foot disease].

Authors:  Lei Gao; Jiangning Wang; Yefeng Yin
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-01-15

3.  Outcome predictors for wound healing in patients with a diabetic foot ulcer.

Authors:  Maryam Mohammad Zadeh; Hester Lingsma; Johan W van Neck; Dalibor Vasilic; Anne-Margreet van Dishoeck
Journal:  Int Wound J       Date:  2019-08-16       Impact factor: 3.315

4.  Microbiological profile and antimicrobial resistance among diabetic foot infections in Lebanon.

Authors:  Lamia Jouhar; Rola F Jaafar; Rakan Nasreddine; Omar Itani; Fady Haddad; Nisrine Rizk; Jamal J Hoballah
Journal:  Int Wound J       Date:  2020-08-11       Impact factor: 3.315

5.  A Decision Tree Analysis of Diabetic Foot Amputation Risk in Indian Patients.

Authors:  Prasad Umesh Kasbekar; Pranay Goel; Shailaja Prakash Jadhav
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-17       Impact factor: 5.555

6.  Effects of adding adjunctive hyperbaric oxygen therapy to standard wound care for diabetic foot ulcers: a protocol for a systematic review with meta-analysis and trial sequential analysis.

Authors:  Julie Vinkel; Niels Frederich Rose Holm; Janus C Jakobsen; Ole Hyldegaard
Journal:  BMJ Open       Date:  2020-06-29       Impact factor: 2.692

7.  The Superiority of Removable Contact Splints in the Healing of Diabetic Foot during Postoperative Care.

Authors:  Vladimíra Fejfarová; Jaroslav Pavlů; Robert Bém; Veronika Wosková; Michal Dubský; Andrea Němcová; Alexandra Jirkovská; Bedřich Sixta; Karol Sutoris; Filip Thieme; David G Armstrong; Eliška Vrátná; Jitka Hazdrová; Věra Lánská
Journal:  J Diabetes Res       Date:  2019-09-15       Impact factor: 4.011

8.  Clinical and surgical characteristics of infected diabetic foot ulcers in a tertiary hospital of Mexico.

Authors:  Estrella Cervantes-García; Paz María Salazar-Schettino
Journal:  Diabet Foot Ankle       Date:  2017-09-06

9.  Association between VEGF genetic variants and diabetic foot ulcer in Chinese Han population: A case-control study.

Authors:  Xiaolei Li; Yonghua Lu; Peng Wei
Journal:  Medicine (Baltimore)       Date:  2018-05       Impact factor: 1.889

10.  Risk factors for lower extremity amputation in patients with diabetic foot ulcers: A meta-analysis.

Authors:  Chunmei Lin; Jinhao Liu; Hu Sun
Journal:  PLoS One       Date:  2020-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.